Cite
68 Ga-fibroblast activation protein inhibitor PET/CT on gross tumour volume delineation for radiotherapy planning of oesophageal cancer.
MLA
Zhao, Liang, et al. “68 Ga-Fibroblast Activation Protein Inhibitor PET/CT on Gross Tumour Volume Delineation for Radiotherapy Planning of Oesophageal Cancer.” Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology, vol. 158, May 2021, pp. 55–61. EBSCOhost, https://doi.org/10.1016/j.radonc.2021.02.015.
APA
Zhao, L., Chen, S., Chen, S., Pang, Y., Dai, Y., Hu, S., Lin, L., Fu, L., Sun, L., Wu, H., Chen, H., & Lin, Q. (2021). 68 Ga-fibroblast activation protein inhibitor PET/CT on gross tumour volume delineation for radiotherapy planning of oesophageal cancer. Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology, 158, 55–61. https://doi.org/10.1016/j.radonc.2021.02.015
Chicago
Zhao, Liang, Shanyu Chen, Sijia Chen, Yizhen Pang, Yaqing Dai, Shenping Hu, Li’e Lin, et al. 2021. “68 Ga-Fibroblast Activation Protein Inhibitor PET/CT on Gross Tumour Volume Delineation for Radiotherapy Planning of Oesophageal Cancer.” Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology 158 (May): 55–61. doi:10.1016/j.radonc.2021.02.015.